vs
American Well Corp（AMWL）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
American Well Corp的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$55.3M vs $35.5M），American Well Corp净利率更高（-45.1% vs -304.2%，领先259.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -22.1%），American Well Corp自由现金流更多（$-17.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -3.6%）
美国烟草公司由J.B.杜克于1890年整合多家美国烟草制造商合并创立，1896年成为道琼斯工业平均指数最初的12支成分股之一。该公司收购了好彩公司及超过200家竞争对手，一度垄断美国烟草行业。1907年美国联邦政府发起反垄断诉讼，最终将该公司分拆为多家企业。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
AMWL vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.3M | $35.5M |
| 净利润 | $-24.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -45.5% | -304.8% |
| 净利率 | -45.1% | -304.2% |
| 营收同比 | -22.1% | 681.7% |
| 净利润同比 | 41.6% | 39.6% |
| 每股收益（稀释后） | $-1.53 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $55.3M | $35.5M | ||
| Q3 25 | $56.3M | $5.2M | ||
| Q2 25 | $70.9M | $19.2M | ||
| Q1 25 | $66.8M | $14.7M | ||
| Q4 24 | $71.0M | $4.5M | ||
| Q3 24 | $61.0M | $26.1M | ||
| Q2 24 | $62.8M | $14.4M | ||
| Q1 24 | $59.5M | $13.8M |
| Q4 25 | $-24.9M | $-108.1M | ||
| Q3 25 | $-32.4M | $-162.3M | ||
| Q2 25 | $-19.7M | $-171.9M | ||
| Q1 25 | $-18.7M | $-202.5M | ||
| Q4 24 | $-42.7M | $-178.9M | ||
| Q3 24 | $-43.5M | $-95.8M | ||
| Q2 24 | $-49.9M | $-97.5M | ||
| Q1 24 | $-72.1M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -45.5% | -304.8% | ||
| Q3 25 | -52.1% | -3327.6% | ||
| Q2 25 | -28.7% | -916.8% | ||
| Q1 25 | -45.5% | -1297.9% | ||
| Q4 24 | -60.2% | -4042.4% | ||
| Q3 24 | -77.6% | -377.1% | ||
| Q2 24 | -83.4% | -697.4% | ||
| Q1 24 | -126.1% | -698.4% |
| Q4 25 | -45.1% | -304.2% | ||
| Q3 25 | -57.5% | -3135.3% | ||
| Q2 25 | -27.8% | -894.2% | ||
| Q1 25 | -28.0% | -1373.3% | ||
| Q4 24 | -60.1% | -3935.5% | ||
| Q3 24 | -71.2% | -367.5% | ||
| Q2 24 | -79.5% | -676.6% | ||
| Q1 24 | -121.1% | -662.4% |
| Q4 25 | $-1.53 | $-0.17 | ||
| Q3 25 | $-2.00 | $-0.36 | ||
| Q2 25 | $-1.24 | $-0.41 | ||
| Q1 25 | $-1.19 | $-0.50 | ||
| Q4 24 | $-2.71 | $-0.56 | ||
| Q3 24 | $-2.87 | $-0.34 | ||
| Q2 24 | $-3.36 | $-0.40 | ||
| Q1 24 | $-4.94 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $182.3M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $235.6M | $1.1B |
| 总资产 | $323.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $182.3M | $743.3M | ||
| Q3 25 | $200.9M | $659.8M | ||
| Q2 25 | $219.1M | $525.1M | ||
| Q1 25 | $222.4M | $500.5M | ||
| Q4 24 | $228.3M | $594.4M | ||
| Q3 24 | $244.6M | $427.6M | ||
| Q2 24 | $276.9M | $474.3M | ||
| Q1 24 | $308.6M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $235.6M | $1.1B | ||
| Q3 25 | $254.9M | $1.0B | ||
| Q2 25 | $282.6M | $919.1M | ||
| Q1 25 | $294.0M | $933.9M | ||
| Q4 24 | $304.8M | $1.0B | ||
| Q3 24 | $336.7M | $524.6M | ||
| Q2 24 | $363.9M | $584.4M | ||
| Q1 24 | $408.7M | $401.2M |
| Q4 25 | $323.8M | $1.5B | ||
| Q3 25 | $359.4M | $1.4B | ||
| Q2 25 | $388.7M | $1.3B | ||
| Q1 25 | $419.5M | $1.3B | ||
| Q4 24 | $436.0M | $1.4B | ||
| Q3 24 | $483.0M | $726.5M | ||
| Q2 24 | $507.8M | $775.9M | ||
| Q1 24 | $548.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | -31.4% | -133.1% |
| 资本支出强度资本支出/营收 | 0.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-17.4M | $-46.1M | ||
| Q3 25 | $-18.8M | $-117.4M | ||
| Q2 25 | $-4.7M | $-76.4M | ||
| Q1 25 | $-25.1M | $-132.0M | ||
| Q4 24 | $-13.4M | $-115.4M | ||
| Q3 24 | $-32.4M | $-59.2M | ||
| Q2 24 | $-21.8M | $-82.2M | ||
| Q1 24 | $-59.8M | $-102.3M |
| Q4 25 | $-17.4M | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $-25.1M | $-133.8M | ||
| Q4 24 | $-13.4M | $-116.7M | ||
| Q3 24 | $-32.4M | $-63.8M | ||
| Q2 24 | $-21.8M | $-83.4M | ||
| Q1 24 | $-59.8M | $-109.0M |
| Q4 25 | -31.4% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | -37.6% | -907.4% | ||
| Q4 24 | -18.9% | -2567.7% | ||
| Q3 24 | -53.0% | -244.6% | ||
| Q2 24 | -34.7% | -578.5% | ||
| Q1 24 | -100.5% | -789.9% |
| Q4 25 | 0.0% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.0% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 0.1% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMWL
| Platform Subscription | $28.8M | 52% |
| Visits | $23.7M | 43% |
| Others | $2.8M | 5% |
RXRX
暂无分部数据
